99 related articles for article (PubMed ID: 24460344)
1. Association of the Cylin D1 G870A polymorphism with laryngeal cancer: are they really related?
Verim A; Ozkan N; Turan S; Korkmaz G; Cacina C; Yaylim I; Isbir T
Asian Pac J Cancer Prev; 2013; 14(12):7629-34. PubMed ID: 24460344
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 gene G870A variants and primary brain tumors.
Zeybek U; Yaylim I; Ozkan NE; Korkmaz G; Turan S; Kafadar D; Cacina C; Kafadar AM
Asian Pac J Cancer Prev; 2013; 14(7):4101-6. PubMed ID: 23991960
[TBL] [Abstract][Full Text] [Related]
3. Association between laryngeal squamous cell carcinoma and polymorphisms in tumor necrosis factor related apoptosis induce ligand (TRAIL), TRAIL receptor and sTRAIL levels.
Verim A; Turan S; Farooqi AA; Kahraman OT; Tepe-Karaca C; Yildiz Y; Naiboglu B; Ozkan NE; Ergen A; Isitmangil GA; Yaylim I
Asian Pac J Cancer Prev; 2014; 15(24):10697-703. PubMed ID: 25605161
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure.
Monteiro E; Varzim G; Pires AM; Teixeira M; Lopes C
Cancer Detect Prev; 2004; 28(4):237-43. PubMed ID: 15350626
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
[TBL] [Abstract][Full Text] [Related]
6. Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma.
Atac A; Riecke B; Assaf AT; Gröbe A; Friedrich RE; Heiland M; Izbicki JR; Kluwe L; Blessmann M
Anticancer Res; 2014 Jan; 34(1):235-8. PubMed ID: 24403468
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between the MTHFRC677T polymorphism and lung cancer in a Turkish population.
Yilmaz M; Kacan T; Sari I; Kilickap S
Asian Pac J Cancer Prev; 2014; 15(15):6333-7. PubMed ID: 25124620
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
[TBL] [Abstract][Full Text] [Related]
9. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
[TBL] [Abstract][Full Text] [Related]
10. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.
Daripally S; Nallapalle SR; Katta S; Prasad VV
Tumour Biol; 2015 Sep; 36(10):7817-30. PubMed ID: 25944167
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma.
Re M; Çeka A; Rubini C; Ferrante L; Zizzi A; Gioacchini FM; Tulli M; Spazzafumo L; Sellari-Franceschini S; Procopio AD; Olivieri F
Laryngoscope; 2015 Sep; 125(9):E306-12. PubMed ID: 26153151
[TBL] [Abstract][Full Text] [Related]
13. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
14. [The prognostic significance of DNA ploidy in laryngeal cancers].
Akçam MT; Akkaya A; Deveci S; Ongürü O; Gerek M; Ozkaptan Y
Kulak Burun Bogaz Ihtis Derg; 2002; 9(6):414-23. PubMed ID: 12499829
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
16. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and immunohistochemistry.
Bachmann K; Neumann A; Hinsch A; Nentwich MF; El Gammal AT; Vashist Y; Perez D; Bockhorn M; Izbicki JR; Mann O
J Surg Oncol; 2015 Mar; 111(3):316-23. PubMed ID: 25470788
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in non-alcoholics.
Nishimoto IN; Pinheiro NA; Rogatto SR; Carvalho AL; Simpson AJ; Caballero OL; Kowalski LP
Oral Oncol; 2004 Jul; 40(6):604-10. PubMed ID: 15063389
[TBL] [Abstract][Full Text] [Related]
19. Alpha-B-crystallin expression in human laryngeal squamous cell carcinoma tissues.
Yilmaz M; Karatas OF; Yuceturk B; Dag H; Yener M; Ozen M
Head Neck; 2015 Sep; 37(9):1344-8. PubMed ID: 24817638
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
